Work

Abstract C71: Overcoming mechanism(s) of resistance to active-site TOR inhibitors in leukemia and lymphoma.

Year: 2011

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-11-c71

Authors: Brandon Beagle, David Fruman

Institution: University of California, Irvine

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2324942791

Cites:

Cited by:

Related to: 10